Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Substance Withdrawal Syndrome

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Substance Withdrawal Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, K; Oswald, I1
Jakowec, DM; Neiman, J; Packham, MA; Rand, ML1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Substance Withdrawal Syndrome

ArticleYear
Possible mechanism for adverse reactions to triazolam.
    Lancet (London, England), 1991, Nov-02, Volume: 338, Issue:8775

    Topics: Alprazolam; Anxiety; Humans; Platelet Activating Factor; Receptors, GABA-A; Substance Withdrawal Syndrome; Triazolam

1991
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal.
    Thrombosis research, 1989, Nov-01, Volume: 56, Issue:3

    Topics: Adult; Aged; Alcoholism; Blood Platelets; Calcium; Ethanol; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Serotonin; Smoking; Stimulation, Chemical; Substance Withdrawal Syndrome; Thromboxane B2

1989